What's Going On With Portage Biotech Shares Tuesday?
What's Going On With Portage Biotech Shares Tuesday?
Portage Biotech Inc. (NASDAQ:PRTG) stock is trading higher after the company announced it signed a letter of intent with Immunova, LLC for the potential sale of its subsidiary.
Portage Biotech Inc.（納斯達克：PRTG）股票在公司宣佈與Immunova, LLC簽署意向書以潛在出售其子公司的消息後上漲。
The Details: According to the letter of intent, Portage and Immunova have agreed to negotiate a definitive option agreement for Immunova to acquire Portage's subsidiary, iOx Therapeutics, Ltd.
詳細信息：根據意向書，Portage和Immunova已同意談判一項最終的選擇協議，允許Immunova收購Portage的子公司iOx Therapeutics, Ltd.
iOx specializes in developing liposomal iNKT agonists, with its lead candidate, PORT-2, showing encouraging early clinical results.
iOx專注於開發脂質體iNKt激動劑，其主要候選藥物PORt-2顯示出令人鼓舞的早期臨床結果。
Brian Horsburgh, PhD, CEO of Immunova, said: "We are delighted to continue our collaboration with Portage and potentially add the iOx assets to our own pipeline, creating a clinical-stage biotech company focused on lipid drugs and delivery systems that empower immune cells to better fight disease. This acquisition represents a leap in our mission to advance innovative therapies to patients who need them most."
Immunova的首席執行官Brian Horsburgh博士表示： 「我們很高興能繼續與Portage合作，並可能將iOx的資產添加到我們自己的項目中，創建一個專注於脂質藥物和遞送系統的臨床階段生物技術公司，以增強免疫細胞更好地對抗疾病。這次收購是我們向需要新療法的患者推進創新療法的使命的重要一步。」
Portage stock is trading with unusually high volume, reaching 30.816 million shares. The average session volume over the past 100 days is 899.38 thousand shares.
Portage股票的成交量異常高，達到3081.6萬股。過去100天的平均交易量爲89.938萬股。
PRTG Price Action: At the time of writing, Portage shares are trading 232.6% higher at $10.75, according to data from Benzinga Pro.
PRTG價格走勢：截至撰寫時，Portage的股票交易價格上漲232.6%，達到10.75美元，數據來自Benzinga Pro。
Image: Image: Emilian Danaila from Pixabay
圖片： 圖片：Emilian Danaila來自Pixabay
譯文內容由第三人軟體翻譯。